Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Assistive Technology Enhancement Of Written Expression For Individuals With Neurodevelopmental Disorders, Laura Greiss Hess, Kerrie Lemons Chitwood, Susan Harris
Assistive Technology Enhancement Of Written Expression For Individuals With Neurodevelopmental Disorders, Laura Greiss Hess, Kerrie Lemons Chitwood, Susan Harris
Collected Faculty and Staff Scholarship
This study involves the use of computer software to assess the use of assistive technology (AT) in individuals with neurodevelopmental disorders. We will present an update of the subjects in the study, including research issues, subject diagnoses and diagnostic trends as assessed through baseline and follow-up testing.
Assistive Technology Enhancement Of Written Expression For Individuals With Neurodevelopmental Disorders [Poster], Laura Greiss Hess, Kerrie Lemons Chitwood, Susan Harris
Assistive Technology Enhancement Of Written Expression For Individuals With Neurodevelopmental Disorders [Poster], Laura Greiss Hess, Kerrie Lemons Chitwood, Susan Harris
Collected Faculty and Staff Scholarship
The purpose of this project is to carry out an intensive training program in subjects with a broad range of neurodevelopmental disabilities to assess the efficacy of assistive technology (AT) intervention.
Acute Reperfusion Therapy In St-Elevation Myocardial Infarction From 1994-2003, Brahmajee K. Nallamouthu, Martha E. Blaney, Susan M. Morris, Lori Parsons, Dave P. Miller, John G. Canto, Hal V. Barron, Harlan M. Krumholz
Acute Reperfusion Therapy In St-Elevation Myocardial Infarction From 1994-2003, Brahmajee K. Nallamouthu, Martha E. Blaney, Susan M. Morris, Lori Parsons, Dave P. Miller, John G. Canto, Hal V. Barron, Harlan M. Krumholz
Collected Faculty and Staff Scholarship
Background—Appropriate utilization of acute reperfusion therapy is not a national performance measure for ST-elevation myocardial infarction at this time, and the extent of its contemporary use among ideal patients is unknown.
Methods—From the National Registry of Myocardial Infarction, we identified 238,291 patients enrolled from June 1994 to May 2003 who were ideally suited for acute reperfusion therapy with fibrinolytic therapy or primary percutaneous coronary intervention. We determined rates of not receiving therapy across 3 time periods (June 1994–May 1997, June 1997–May 2000, June 2000– May 2003) and evaluated factors associated with underutilization.
Results—The proportion of ideal patients …